Trial Type: Gastric Cancer

LS-P-CAPE
A Phase II, Open-label, Multi-centre Study to Evaluate Safety, Tolerability, Efficacy, PK, and Immunogenicity of AZD0901 as Monotherapy and in Combination with Anti-cancer Agents in Participants with Advanced Solid Tumours Expressing Claudin 18.2
Status: Open
Trial Type: Gastric Cancer, Pancreas Cancer
Contact: Alex Raufi, MD
araufi2@brownhealth.org
LS-P-HAT
A Phase 1 Study of NM32-2668 (Anti ROR1/Anti CD3/Anti-HSA Tri-Specific Antibody) in Adult Patients with Selected Advanced Solid Tumors
Status: Open
Trial Type: Breast Cancer, Early Phase Trials for Multiple Cancer Types, Esophageal Cancer, Gastric Cancer, Kidney and Bladder Cancer, Lung Cancer, Melanoma and Skin Cancers, Ovarian Cancer, Soft Tissue and Bone Cancer, Uterine Cancer
Contact: Benedito Carneiro, MD
Benedito.carneiro@brownhealth.org
LS-P-DisTinGuish
DKN-01, Tislelizumab ± Chemotherapy as First-Line or Second-Line Therapy for metastatic gastric and esophageal cancer
Status: Open
Trial Type: Gastric Cancer
Contact: Khaldoun Almhanna, MD
kalmhanna@brownhealth.org
LS-P-TIDE
inhibitor of MTAP for patients with MTAP gene alterations in gastric esophageal, NSCLC and bladder cancer
Status: Open
Trial Type: Early Phase Trials for Multiple Cancer Types, Esophageal Cancer, Gastric Cancer, Kidney and Bladder Cancer, Lung Cancer
Contact: Benedito Carneiro, MD
Benedito.carneiro@brownhealth.org

©2025 Brown Cancer Trials